Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $43
3/19/2026
Impact: 75
Healthcare
Canaccord Genuity analyst William Plovanic has maintained a Buy rating on HeartFlow (NASDAQ: HTFL) and increased the price target from $40 to $43.
AI summary, not financial advice
Share: